BIOFIL CHEMICALS & PHARMACEUTICALS LTD.

Biofil Chemicals & Pharmaceuticals Ltd announced that its 41st Annual General Meeting (AGM) will be held on Wednesday, September 23, 2026, at 3:00 PM IST. The meeting will be conducted through Video Conferencing (VC)/Other Audio Visual Means (OAVM). In compliance with SEBI regulations and the Companies Act, the company is providing members with the facility to cast their votes electronically. E-voting will commence on Sunday, September 20, 2026, at 9:00 AM and conclude on Tuesday, September 22, 2026, at 5:00 PM. The cut-off date for e-voting entitlement is September 16, 2026. The AGM will address four resolutions, with results to be announced within two working days of the meeting's conclusion.

Biofil Chemicals & Pharmaceuticals Ltd is informing shareholders whose email addresses are not registered that their Annual Report for FY 2025-26 and the 41st AGM notice are available online. The company is sending a letter with web-links to these shareholders as per SEBI regulations. The 41st AGM is scheduled for September 23, 2026, via VC/OAVM. Shareholders can access the report at https://biofilgroup.net/investor/regulatory-disclosure/financial-reports and https://www.biofilgroup.net/investor/financial-reports. Physical copies can be requested via email, and documents are also available on stock exchange websites.

Biofil Chemicals & Pharmaceuticals Ltd has submitted its Integrated Annual Report for the Financial Year 2025-26, along with the Notice convening its 41st Annual General Meeting (AGM). The AGM is scheduled for Wednesday, September 23, 2026, at 3:00 PM IST, to be held via Video Conference (VC)/Other Audio Visual Means (OAVM). The report and notice have been sent electronically to members and are also available on the company's website (www.biofilgroup.net) and the Central Depository Services (India) Limited website (www.evotingindia.com). The filing complies with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Biofil Chemicals & Pharmaceuticals Ltd has announced its 41st Annual General Meeting (AGM) will be held on Wednesday, September 23, 2026, at 3:00 PM IST. The meeting will be conducted through video conferencing (VC) or other audio-visual means (OAVM), with the registered office deemed as the venue. Key agenda items include the adoption of audited financial statements for the fiscal year ended March 31, 2026, the re-appointment of Mr. Smitesh Shah as a director, and a special resolution for the continuation of Mr. Ashok Kumar Ramawat's directorship beyond age 75. An approval for material related party transactions with Cyano Pharma Private Limited is also on the agenda. The notice of the AGM is available on the company's website and the e-voting portal.

Biofil Chemicals & Pharmaceuticals Ltd announced the continuation of Mr. Ashok Kumar Ramawat's directorship as a Non-executive Independent Director, despite him crossing the age of 75. This decision, approved by the Board of Directors upon the Nomination and Remuneration Committee's recommendation, is subject to shareholder approval via a Special Resolution at the upcoming 41st Annual General Meeting. Mr. Ramawat, with a Bachelor's degree in Science and 46 years of experience in the pharmaceutical industry, is not related to any other directors or KMPs and is not debarred from holding office. The company is also submitting the disclosure in XBRL format and will make the information available on its website.

Biofil Chemicals & Pharmaceuticals Ltd announced its un-audited financial results for the quarter ended June 30, 2026. The Board of Directors also approved the continuation of Mr. Ashok Kumar Ramawat's directorship and convened the 41st Annual General Meeting for September 23, 2026. The company will submit its results in XBRL format and upload them to its website and stock exchange portals. The Board meeting took place on August 11, 2026.

Biofil Chemicals & Pharmaceuticals Ltd announced that its Board of Directors, in a meeting held on August 11, 2026, approved the un-audited financial results for the quarter ended June 30, 2026. The board also approved the Board's Report, Corporate Governance Report, and Management Discussion and Analysis Report for the year ended March 31, 2026. Additionally, the company will convene its 41st Annual General Meeting on September 23, 2026, via Video Conferencing. The continuation of Mr. Ashok Kumar Ramawat's directorship was also approved.

Biofil Chemicals & Pharmaceuticals Ltd has announced that its Board of Directors will convene on August 11, 2026, to consider and approve the Un-Audited Financial Results for the first quarter ended June 30, 2026, along with the Limited Review Report. The meeting will also address other routine matters. Following the declaration of results, the trading window for dealing in the company's securities will reopen 48 hours after the results are announced, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015. The company is submitting this information in both XBRL and PDF formats.

Biofil Chemicals & Pharmaceuticals Ltd has announced the closure of its trading window for the quarter ended June 30, 2026. This closure, effective July 1, 2026, is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will reopen 48 hours after the un-audited financial results for the quarter are declared to the stock exchanges. All designated persons, their immediate relatives, and connected persons are restricted from trading in the company's securities during this period. The date for the board meeting to consider these results will be announced later.

Biofil Chemicals & Pharmaceuticals Ltd. announced its audited financial results for the year ended March 31, 2026, following a Board of Directors meeting held on May 30, 2026. The results, along with the audit report, statement of assets and liabilities, and cash flow statement, were approved. The company will submit the results in XBRL mode and upload them on its website and stock exchange websites. A publication with a QR code linking to the complete financial results will be published in Hindi and English newspapers.